Dr Martin Juneau

Dr Martin Juneau, M.D., FRCP

Cardiologue, directeur de l'Observatoire de la prévention de l'Institut de Cardiologie de Montréal. Professeur titulaire de clinique, Faculté de médecine de l'Université de Montréal. / Cardiologist and Director of Prevention Watch, Montreal Heart Institute. Clinical Professor, Faculty of Medicine, University of Montreal.

Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity
2 March 2023
 | 
Dr Martin Juneau, M.D., FRCP

Initially developed to treat patients with type 2 diabetes, these drugs also cause significant weight loss and are establishing themselves as the first truly effective pharmacological treatments for obesity.

The pros and cons of alcohol
30 January 2023
 | 
Dr Martin Juneau, M.D., FRCP

This is an updated version of an article originally published in 2018 Even though alcohol has been a daily part of human existence for millennia, the substance is far from innocuous and in fact has very complex effects on health. This complexity is well illustrated by the J-shaped relationship between the quantity of alcohol consumed […]

Gut microorganisms boost motivation to exercise
25 January 2023
 | 
Dr Martin Juneau, M.D., FRCP

In mice, certain species of gut bacteria produce molecules that activate nerves that are connected to the brain, thereby stimulating reward circuits associated with exercise.

Is exercising late in the morning associated with a reduced risk of cardiovascular disease?
14 December 2022
 | 
Dr Martin Juneau, M.D., FRCP

For the same amount, physical exercise performed in the late morning rather than at another time of day was associated with a lower risk of cardiovascular disease, according to a study carried out among 86,657 participants from the UK-Biobank cohort.

Yoga and other holistic practices improve blood sugar control in diabetics
17 November 2022
 | 
Dr Martin Juneau, M.D., FRCP

According to a meta-analysis of 28 intervention studies, holistic practices (involving the body and mind), especially yoga, improve blood sugar control in people with type 2 diabetes.

Replacing tobacco with e-cigarettes reduces the risk of cardiovascular events
4 October 2022
 | 
Dr Martin Juneau, M.D., FRCP

People who exclusively use electronic cigarettes as a source of nicotine reduce their risk of cardiovascular disease by 33% compared to smokers.

Association between red meat consumption and the risk of cardiovascular disease: An important role of L-carnitine metabolites
13 September 2022
 | 
Dr Martin Juneau, M.D., FRCP

A new American study shows an unfavourable association between red meat consumption and the incidence of cardiovascular disease, an association attributable in part to TMAO and other L-carnitine metabolites.

Time-restricted eating, a promising approach for chronic disease prevention
12 August 2022
 | 
Dr Martin Juneau, M.D., FRCP

How can we explain that the simple fact of restricting caloric intake to a shorter window of time can lead to significant health benefits?

Vigorous exercise decreases appetite and promotes weight loss through the production of the metabolite Lac-Phe
5 August 2022
 | 
Dr Martin Juneau, M.D., FRCP

A recent study shows that a metabolite, N-lactoyl-phenylalanine (Lac-Phe), produced during and after vigorous exercise, decreases appetite and promotes weight loss.

Harmful health effects of exposure to “Forever Chemicals”
8 July 2022
 | 
Dr Martin Juneau, M.D., FRCP

Per- and polyfluoroalkyl substances (PFAS), nicknamed “Forever Chemicals” because of their very high stability, and which are used in everyday consumer products (e.g., cosmetics, packaging), can have harmful effects on human health.

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.